Antiviral pills: COVID-19 treatment at our fingertips

With the global pandemic coming close to its two year anniversary, exciting progress is being made in the treatment and prevention of the deadly virus. Antiviral drugs have been used to treat several infections in the past, and can be administered in many different forms. Scientists are now developing antiviral pills to help in the treatment of patients infected with the SARS-CoV-2 virus. This video explores the roles of antiviral drugs in treating viral infections, and describes two forerunners in antiviral pill development. Merck & Co recently submitted an FDA application for their investigational drug Molnupiravir, and Pfizer’s investigational drug PF-07321332 is in the human subject testing phase. Both of these pills aim to treat patients diagnosed with COVID-19 and to decrease hospitalizations and deaths caused by the SARS-CoV-2 virus. While these pills are new and exciting, they should be used as an additional tool alongside vaccines. Watch this video to find out more about these antiviral pills and the treatment of COVID-19.

[Please complete our feedback form]